Burson-Marsteller has appointed Kate Hawker as the new MD and chair of its EMEA and UK healthcare divisions.
“Kate is an excellent, and welcome, addition to Burson-Marsteller’s outstanding group of EMEA practice chairs,” said Jeremy Galbraith, CEO of Burson-Marsteller EMEA.
“She brings the healthcare expertise and individual creativity that clients justifiably expect from a leading global agency and I am delighted she is joining us.”
She joins the agency after three years as business development director for InforMed, following the acquisition of her start-up medical communications company Medea.
During her 25-year career Hawker has directed pan-European and UK medical communications and PR programmes, having worked on campaigns for GSK, Baxter, Takeda, Boehringer-Ingelheim, Bristol Meyer Squibb, MSD and others.
She has also been a director and partner at Fleishman-Hillard, director at OCC and associate director for Shire Health International.
Commenting on her appointment, Hawker said: “I’m delighted to be joining Burson-Marsteller, an agency with a stand-out reputation for delivering integrated communications campaigns on a UK, EMEA and global level. I’m looking forward to working with a great team both in the UK and across EMEA.”